Sandoz
Karen H. has extensive experience in senior leadership and board roles across various companies in the pharmaceutical and diagnostics sectors, currently serving as a member of the Board of Directors at Ivoclar and Vice Chair of the Board of Directors at Sandoz. Additional roles include Non Executive Director at BBI Solutions, Foundation Board Member at IMD, and Vice Chair of the Board of Directors for Tecan. Notably, Karen H. was the Group CEO and Board Member at Solvias AG, and held significant positions at Novartis, including Head of European Public Health and Global Head of Investor Relations. Education includes an MBA from IMD and a PhD in Molecular Biology from ETH Zürich.
This person is not in any teams
This person is not in any offices
Sandoz
30 followers
As a division of the Novartis Group, their purpose is to discover new ways to improve and extend people's lives. They contribute to society's ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine.